Wednesday, July 8, 2026

pharma · NASH With Fibrosis · NASH - Nonalcoholic Steatohepatitis · HEPA

Hepion Pharmaceuticals

Hepion Pharmaceuticals trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Morristown, USA HQ
4 Employees
Public company Type
HEPA · NYSE Ticker
Company details
Status
Public
HQ
Morristown, USA
Employees
4
Programs
5
Drugs
2
Patents
1
Intelligence · Clinical Trials

Hepion Pharmaceuticals clinical trials

Registry index of 5 ClinicalTrials.gov studies linked to Hepion Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Hepion Pharmaceuticals trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

5 updates

Latest clinical program signals indexed for Hepion Pharmaceuticals.

  1. CRV431 — Phase 1

    Clinical update
  2. Rencofilstat — Phase 2

    Clinical update
  3. CRV431 75mg — Phase 2

    Clinical update
  4. rencofilstat, 75 mg — Phase 2

    Clinical update
  5. [14C]-rencofilstat 225mg — Phase 1

    Clinical update

Trial registry

5 studies